Squarepoint’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-17,561
| Closed | -$93K | – | 3025 |
|
|
2021
Q2 | $93K | Sell |
17,561
-39,923
| -69% | -$211K | ﹤0.01% | 2430 |
|
|
2021
Q1 | $276K | Buy |
57,484
+17,662
| +44% | +$84.8K | ﹤0.01% | 1940 |
|
|
2020
Q4 | $172K | Sell |
39,822
-42,541
| -52% | -$184K | ﹤0.01% | 2190 |
|
|
2020
Q3 | $339K | Buy |
82,363
+72,336
| +721% | +$298K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $26K | Buy |
+10,027
| New | +$26K | ﹤0.01% | 2071 |
|
|
2020
Q1 | – | Sell |
-30,177
| Closed | -$114K | – | 2680 |
|
|
2019
Q4 | $114K | Buy |
+30,177
| New | +$114K | ﹤0.01% | 2234 |
|
|
2019
Q3 | – | Sell |
-19,803
| Closed | -$123K | – | 2666 |
|
|
2019
Q2 | $123K | Buy |
+19,803
| New | +$123K | ﹤0.01% | 2126 |
|
|
2019
Q1 | – | Sell |
-24,720
| Closed | -$211K | – | 2481 |
|
|
2018
Q4 | $211K | Sell |
24,720
-27,680
| -53% | -$236K | ﹤0.01% | 1650 |
|
|
2018
Q3 | $1.05M | Sell |
52,400
-77,474
| -60% | -$1.55M | 0.01% | 964 |
|
|
2018
Q2 | $3.36M | Buy |
129,874
+94,882
| +271% | +$2.45M | 0.04% | 490 |
|
|
2018
Q1 | $836K | Buy |
34,992
+12,164
| +53% | +$291K | 0.01% | 868 |
|
|
2017
Q4 | $774K | Buy |
22,828
+11,532
| +102% | +$391K | 0.01% | 942 |
|
|
2017
Q3 | $239K | Buy |
+11,296
| New | +$239K | ﹤0.01% | 1276 |
|